Skip to main content

NATIXIS ADVISORS, LLC

Position in TAK — Takeda Pharmaceutical Co Ltd

CIK 1018331 Boston, MA

Position in TAK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,301,297
-$1,699,812 QoQ
Shares Held
268,328
-17.2% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#49
of 375 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TAK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

NATIXIS ADVISORS, LLC holds $144,607,995 across 17 Drug Manufacturers - Specialty & Generic names. TAK ranks #8 (3.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 TAK
Takeda Pharmaceutical Co Ltd
This page
268,328 $4,301,297

All Filings in TAK

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,301,297 268,328
2026-03-31 $6,001,109 324,034
2025-12-31 $3,550,684 227,754
2025-09-30 $7,032,646 480,372
2025-06-30 $7,011,527 453,527
2025-03-31 $6,249,533 420,278
2024-12-31 $6,336,385 478,579
2024-09-30 $6,499,108 457,040
2024-06-30 $6,057,356 468,111
2024-03-31 $9,476,994 682,289
2023-12-31 $9,362,603 656,104
2023-09-30 $10,394,091 671,887
2023-06-30 $10,384,780 661,030
2023-03-31 $11,378,252 690,428
2022-12-31 $11,177,228 716,489
2022-09-30 $9,953,735 767,443
2022-06-30 $8,681,338 618,329
2022-03-31 $8,755,376 611,409
2021-12-31 $5,500,222 403,538
2021-09-30 $9,334,502 569,872
2021-06-30 $8,851,418 525,931
2021-03-31 $9,357,811 512,476
2020-12-31 $5,815,554 319,536
2020-09-30 $5,057,729 283,505
2020-06-30 $4,789,300 267,111
2020-03-31 $4,147,737 273,237